Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Larsen

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|April 14, 2010
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabantHenrik H Hansen, Gitte Hansen, Mads Tang-Christensen, et al.
European Journal of Pharmacology|May 15, 2002
Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptidesPhilip J Larsen, Niels Vrang, Mads Tang-Christensen, et al.
Obesity (Silver Spring, Md.)|August 8, 2009
Characterization of beta-cell mass and insulin resistance in diet-induced obese and diet-resistant ratsSarah J Paulsen, Jacob Jelsing, Andreas N Madsen, et al.
Diabetes, Obesity & Metabolism|August 10, 2018
A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trialsJoachim Tillner, Maximilian G Posch, Frank Wagner, et al.
Diabetes|February 6, 2021
Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission TomographyOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2020
Imaging of the Glucagon Receptor in Subjects with Type 2 DiabetesOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 DiabetesOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Scientific Reports|October 20, 2019
Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primatesOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Biochimica Et Biophysica Acta|December 8, 2009
ADD1/SREBP1c activates the PGC1-alpha promoter in brown adipocytesQin Hao, Jacob B Hansen, Rasmus K Petersen, et al.
Endocrinology|July 12, 2018
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic MonkeysRalf Elvert, Martin Bossart, Andreas W Herling, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|April 14, 2010
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabantHenrik H Hansen, Gitte Hansen, Mads Tang-Christensen, et al.
European Journal of Pharmacology|May 15, 2002
Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptidesPhilip J Larsen, Niels Vrang, Mads Tang-Christensen, et al.
Obesity (Silver Spring, Md.)|August 8, 2009
Characterization of beta-cell mass and insulin resistance in diet-induced obese and diet-resistant ratsSarah J Paulsen, Jacob Jelsing, Andreas N Madsen, et al.
Diabetes, Obesity & Metabolism|August 10, 2018
A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trialsJoachim Tillner, Maximilian G Posch, Frank Wagner, et al.
Diabetes|February 6, 2021
Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission TomographyOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2020
Imaging of the Glucagon Receptor in Subjects with Type 2 DiabetesOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 DiabetesOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Scientific Reports|October 20, 2019
Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primatesOlof Eriksson, Irina Velikyan, Torsten Haack, et al.
Biochimica Et Biophysica Acta|December 8, 2009
ADD1/SREBP1c activates the PGC1-alpha promoter in brown adipocytesQin Hao, Jacob B Hansen, Rasmus K Petersen, et al.
Endocrinology|July 12, 2018
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic MonkeysRalf Elvert, Martin Bossart, Andreas W Herling, et al.
Pageof 4